Minimal toxicity with 3-FAT radiotherapy of prostate cancer.

Seminars in urologic oncology Pub Date : 2000-05-01
M D Weil, E D Crawford, P Cornish, W Dzingle, K Stuhr, B Pickett, M Roach
{"title":"Minimal toxicity with 3-FAT radiotherapy of prostate cancer.","authors":"M D Weil,&nbsp;E D Crawford,&nbsp;P Cornish,&nbsp;W Dzingle,&nbsp;K Stuhr,&nbsp;B Pickett,&nbsp;M Roach","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Beam radiation with three-dimensional conformal planning appears to decrease morbidity of prostate cancer therapy. The 3-field, arc technique (3-FAT) technique was designed by computer modeling to improve radiation dose to the target and minimize dispersion to nearby organs. Toxicity was studied in patients with prostate cancer. We performed a retrospective study of 168 consecutive men with prostate cancer after 3-FAT radiotherapy with a median follow-up of 24 months. All patients, treated from 1996 through 1999 at the University of Colorado had a pathological diagnosis of cancer before irradiation. Therapy was designed with a urethrogram and planning computed tomography scan. The 3-FAT was employed using noncoplanar, rotational beams, and nonuniform blocking of portals. Patients were treated to a minimal tumor dose of 74 Gy in 37 fractions. Adverse effects were investigated. Definitive radiotherapy was given to 80% of the group, and 58% received total androgen blockade. 3-FAT produced favorable dose distributions for the rectum, bladder, femoral heads, and base of the penis. Patients routinely report minimal dysuria and frequency during treatment. There were minimal urinary complaints after irradiation and no proctitis, diarrhea, incontinence, or change in potency as a result of radiotherapy. The 3-FAT represents a technical improvement in the treatment of prostate cancer by minimizing radiation delivered to adjacent critical structures. There were minimal side effects to the rectum, bladder, and penis base despite high doses to the prostate and seminal vesicles. The large percentage of patients with preliminary prostate-specific antigen values below 1.0 portends efficacy.</p>","PeriodicalId":79436,"journal":{"name":"Seminars in urologic oncology","volume":"18 2","pages":"127-32"},"PeriodicalIF":0.0000,"publicationDate":"2000-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in urologic oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Beam radiation with three-dimensional conformal planning appears to decrease morbidity of prostate cancer therapy. The 3-field, arc technique (3-FAT) technique was designed by computer modeling to improve radiation dose to the target and minimize dispersion to nearby organs. Toxicity was studied in patients with prostate cancer. We performed a retrospective study of 168 consecutive men with prostate cancer after 3-FAT radiotherapy with a median follow-up of 24 months. All patients, treated from 1996 through 1999 at the University of Colorado had a pathological diagnosis of cancer before irradiation. Therapy was designed with a urethrogram and planning computed tomography scan. The 3-FAT was employed using noncoplanar, rotational beams, and nonuniform blocking of portals. Patients were treated to a minimal tumor dose of 74 Gy in 37 fractions. Adverse effects were investigated. Definitive radiotherapy was given to 80% of the group, and 58% received total androgen blockade. 3-FAT produced favorable dose distributions for the rectum, bladder, femoral heads, and base of the penis. Patients routinely report minimal dysuria and frequency during treatment. There were minimal urinary complaints after irradiation and no proctitis, diarrhea, incontinence, or change in potency as a result of radiotherapy. The 3-FAT represents a technical improvement in the treatment of prostate cancer by minimizing radiation delivered to adjacent critical structures. There were minimal side effects to the rectum, bladder, and penis base despite high doses to the prostate and seminal vesicles. The large percentage of patients with preliminary prostate-specific antigen values below 1.0 portends efficacy.

3-FAT放射治疗前列腺癌的最小毒性。
具有三维适形规划的放射治疗似乎可以降低前列腺癌治疗的发病率。通过计算机模拟设计了3场电弧技术(3-FAT),以提高对靶的辐射剂量,减少对附近器官的散射。对前列腺癌患者进行了毒性研究。我们对168名连续接受3-FAT放射治疗的前列腺癌患者进行了回顾性研究,中位随访时间为24个月。从1996年到1999年在科罗拉多大学接受治疗的所有患者在放疗前都有癌症病理诊断。采用尿道造影和计算机断层扫描设计治疗方案。3-FAT采用非共面、旋转光束和非均匀阻挡入口。患者接受的最小肿瘤剂量为74 Gy,分为37个部分。对不良反应进行了调查。80%的患者接受了最终放疗,58%的患者接受了全雄激素阻断治疗。3-FAT在直肠、膀胱、股骨头和阴茎基部产生良好的剂量分布。在治疗期间,患者通常报告最小的排尿困难和频率。放疗后泌尿系统疾病极少,无直肠炎、腹泻、尿失禁或放射治疗引起的效力改变。3-FAT通过减少对邻近关键结构的辐射,代表了前列腺癌治疗的技术进步。尽管对前列腺和精囊有高剂量的影响,但对直肠、膀胱和阴茎基部的副作用很小。前列腺特异性抗原初步值低于1.0的患者比例大,预示着疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信